Anais Brasileiros de Dermatologia
Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications
Paulo Ricardo Criado; Roberta Fachini Jardim Criado; Hélio Amante Miot; Beatrice Martinez Zugaib Abdalla; Helena Zenedin Marchioro; Renan Rangel Bonamigo;
An Bras Dermatol. 2025;100:
Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria
Fikriye Kalkan; Sait Yeşillik; Fevzi Demirel; Ezgi Sönmez; Yasemin Balaban; Mustafa İlker İnan; Özgür Kartal;
An Bras Dermatol. 2025;100:31-7
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
Emek Kocatürk; Emel Bülbül Başkan; Özlem Su Küçük; Mustafa Özdemir; Sinem Örnek; Pelin Kuteyla Can; Eda Haşal; Burhan Engin; Nilgün Atakan; Erkan Alpsoy;
An Bras Dermatol. 2022;97:592-600